An in vitro study of the dynamic features of the major histocompatibility complex class I complex relevant to its role as a versatile peptide-receptive molecule

par Hörig, Heidi, Papadopoulos, Nicholas J., Vegh, Zsuzsanna, Palmieri, Edith, Angeletti, Ruth H., Nathenson, Stanley G.
Publié 1997

T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell

par González, Pablo A., Carreño, Leandro J., Coombs, Daniel, Mora, Jorge E., Palmieri, Edith, Goldstein, Byron, Nathenson, Stanley G., Kalergis, Alexis M.
Publié 2005

Structure-guided development of a high-affinity human Programmed Cell Death-1: Implications for tumor immunotherapy

par Lázár-Molnár, Eszter, Scandiuzzi, Lisa, Basu, Indranil, Quinn, Thomas, Sylvestre, Eliezer, Palmieri, Edith, Ramagopal, Udupi A., Nathenson, Stanley G., Guha, Chandan, Almo, Steven C.
Publié dans EBioMedicine (2017)

Predominant occupation of the class I MHC molecule H-2K(wm7) with a single self-peptide suggests a mechanism for its diabetes-protective effect

par Brims, Daniel R., Qian, Jie, Jarchum, Irene, Mikesh, Leann, Palmieri, Edith, Ramagopal, Udupi A., Malashkevich, Vladimir N., Chaparro, Rodolfo J., Lund, Torben, Hattori, Masakazu, Shabanowitz, Jeffrey, Hunt, Donald F., Nathenson, Stanley G., Almo, Steven C., DiLorenzo, Teresa P.
Publié 2010